Renascience
4889.TPharmaceutical
Filed as Renascience, Inc (2022-06–2022-06)
In English · 5
Mon, Jun 16 · JST1 filing
15:355% STAKERenascience · DCI Partners Co., Ltd. · 5.76% → 4.59%−1.17ppMon, Feb 3 · JST1 filing
15:545% STAKERenascience · DCI Partners Co., Ltd. · 6.83% → 5.76%−1.07ppWed, Jan 22 · JST1 filing
15:475% STAKERenascience · DCI Partners Co., Ltd. · 8.73% → 6.83%−1.90ppTue, Jan 21 · JST1 filing
16:065% STAKERenascience · DCI Partners Co., Ltd. · 10.22% → 8.73%−1.49ppFri, Dec 20 · JST1 filing
14:365% STAKERenascience · Toshio Miyata · 22.97% → 21.53%−1.44ppAll EDINET filings · 65
| Filed | Document | Source |
|---|---|---|
| 2026-06-23 | Internal control report | S100YH4O |
| 2026-06-23 | CEO/CFO certification | S100YH2K |
| 2025-11-12 | CEO/CFO certification | S100X1PJ |
| 2025-09-03 | CEO/CFO certificationRelated to S100WM4A | S100WN0Q |
| 2025-06-24 | Internal control report | S100W36E |
| 2025-06-24 | CEO/CFO certification | S100W366 |
| 2024-11-14 | CEO/CFO certification | S100URRQ |
| 2024-06-28 | Internal control report | S100TX7Q |
| 2024-06-28 | CEO/CFO certification | S100TX6L |
| 2024-02-08 | CEO/CFO certification | S100SSJ4 |
| 2023-11-09 | CEO/CFO certification | S100S5N2 |
| 2023-06-30 | Internal control report | S100RAGO |
| 2023-06-30 | CEO/CFO certification | S100RAFL |
| 2022-06-30 | Internal control report | S100OMF5 |
| 2022-06-30 | CEO/CFO certification | S100OMEY |
EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 2 financial reports not structured yet.